Pain management

Abstract

The present invention relates to Pain Management and to a process for producing a transdermal pain formulation, in liquid, viscous, or roll on device, including a composition including a. Astragalus at about 10% of the composition b. Cat's Claw at about 10% of the composition c. Mistletoe at about 10% of the composition d. Sheep Sorrel at about 10% of the composition e. Green Tea at about 10% of the composition f. Capsaicin at about 10% of the composition g. Nettle leaf at about 10% of the composition h. Skull cap at about 10% of the composition i. L-Glutamine at bout 10% of the composition j. Fat soluble Ascorbyl Palmitate form of Vitamin C at about 10% of the composition k. In which to the substances in (a) to (j) is added Alcohol-H 2 O Tincture, in a ration of 1:1:1 on all herbal substances in (a) to (j) and concentrated to about a 50% reduction, and to which a final addition of Ascorbyl Palmitate and L-Glutamine in an ½ half to ½ half ratio to the concentrated tincture, so as to be combined in a predetermined varied quantities of (k), resulting in a liquid, viscous cream form, or roll-on device, with the addition of a Liposomal transdermal carrier.

1 . A process for producing a transdermal pain formulation, in liquid, viscous, or roll on device, including a composition constituted by the steps in which to the substances in (a) to (j) as stated below in the composition is added Alcohol-H 2 O Tincture, in a ratio of 1:1:1 on all herbal substances in (a) to (j) and concentrated to about a 50% reduction, and to which a final addition of Ascorbyl Palmitate and L-Glutamine in an ½ half to ½ half ratio to the concentrated tincture, so as to be combined in a predetermined varied quantities resulting in a liquid, viscous cream form, or roll-on device, with the addition of a Liposomal transdermal carrier, the composition being 
 a. Astragalus at about 10% of the composition;    b. Cat's Claw at about 10% of the composition;    c. Mistletoe at about 10% of the composition;    d. Sheep Sorrel at about 10% of the composition;    e. Green Tea at about 10% of the composition;    f. Capsaicin at about 10% of the composition;    g. Nettle leaf at about 10% of the composition;    h. Skul cap at about 10% of the composition;    i. L-Glutamine at about 10% of the composition;    j. Fat soluble Ascorbyl Palmitate form of Vitamin C at about 10% of the composition.    
     
     
         2 . A process as claimed  1 , in which the ratio of the transdermal carrier is about 60% of the total substance mix, to which is added the about 40% of active substances to constitute a roll-on device.